arabinofuranosylcytosine triphosphate has been researched along with Leukemia, Lymphocytic in 14 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 12 (85.71) | 18.7374 |
1990's | 2 (14.29) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Abe, I; Hori, K; Saito, S; Sato, H; Suzuki, M | 1 |
Bowman, WP; Danks, MK; Look, AT; Ochs, J; Rivera, G; Sinkule, JA | 1 |
Barlogie, B; Chubb, S; Plunkett, W | 1 |
TAnaka, M; Yoshida, S | 1 |
Bauer, S; Cinatl, J; Köhl, U; Mainke, M; Mieth, B; Montag, E; Rohrbach, E; Schwabe, D; Weissflog, A | 1 |
Bouffard, DY; Momparler, LF; Momparler, RL; Onetto-Pothier, N | 1 |
Fridland, A; Verhoef, V | 1 |
Finch, LR; Jamieson, GP; Snook, M; Wiley, JS | 1 |
Avramis, VI; Biener, R; Ettinger, L; Finklestein, J; Holcenberg, JS; Krailo, M; Siegel, SE; Willoughby, M | 1 |
Firkin, FC; Jamieson, GP; Sawyer, WH; Wiley, JS; Woodruff, RK | 1 |
Preisler, HD; Riva, CM; Rustum, YM | 1 |
Andersson, B; Beran, M; Estey, E; Freireich, EJ; Iacoboni, S; Kantarjian, H; Keating, MJ; McCredie, KB; Plunkett, W; Walters, R | 1 |
Finch, LR; Jamieson, GP; Sawyer, WH; Snook, M; Taupin, J; Wiley, JS | 1 |
Capizzi, RL; Cooper, MR; Jackson, DV; Muss, HB; Powell, BL; Richards, F; Spurr, CL; Stuart, JJ; White, DR; Zekan, PJ | 1 |
1 review(s) available for arabinofuranosylcytosine triphosphate and Leukemia, Lymphocytic
Article | Year |
---|---|
Sequential high-dose ara-C and asparaginase in the therapy of previously treated and untreated patients with acute leukemia.
Topics: Aging; Animals; Antineoplastic Combined Chemotherapy Protocols; Arabinofuranosylcytosine Triphosphate; Asparaginase; Child; Clinical Trials as Topic; Cytarabine; Daunorubicin; DNA; Dose-Response Relationship, Drug; Drug Resistance; Humans; Kinetics; Leukemia; Leukemia, Lymphoid; Middle Aged; Time Factors | 1985 |
1 trial(s) available for arabinofuranosylcytosine triphosphate and Leukemia, Lymphocytic
Article | Year |
---|---|
Sequential high-dose ara-C and asparaginase in the therapy of previously treated and untreated patients with acute leukemia.
Topics: Aging; Animals; Antineoplastic Combined Chemotherapy Protocols; Arabinofuranosylcytosine Triphosphate; Asparaginase; Child; Clinical Trials as Topic; Cytarabine; Daunorubicin; DNA; Dose-Response Relationship, Drug; Drug Resistance; Humans; Kinetics; Leukemia; Leukemia, Lymphoid; Middle Aged; Time Factors | 1985 |
13 other study(ies) available for arabinofuranosylcytosine triphosphate and Leukemia, Lymphocytic
Article | Year |
---|---|
Prediction of sensitivity to 1-beta-D-arabinofuranosylcytosine by the plateau level of its 5'-triphosphate in human lymphoblastic cell lines in vitro.
Topics: Arabinofuranosylcytosine Triphosphate; Arabinonucleotides; Burkitt Lymphoma; Cell Line; Cytarabine; DNA; Humans; Leukemia, Lymphoid | 1983 |
Continuous infusion high-dose cytosine arabinoside in refractory childhood leukemia.
Topics: Acute Disease; Adolescent; Arabinofuranosylcytosine Triphosphate; Bone Marrow; Child; Child, Preschool; Cytarabine; Deoxycytosine Nucleotides; Drug Administration Schedule; Humans; Infusions, Parenteral; Kinetics; Leukemia; Leukemia, Lymphoid | 1984 |
Simultaneous determination of 1-beta-D-arabinofuranosylcytosine 5'-triphosphate and 3-deazauridine 5'-triphosphate in human leukemia cells by high-performance liquid chromatography.
Topics: 3-Deazauridine; Arabinofuranosylcytosine Triphosphate; Arabinonucleotides; Cells, Cultured; Chromatography, High Pressure Liquid; Cytarabine; Cytidine Triphosphate; Humans; Leukemia; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Uracil Nucleotides; Uridine; Uridine Triphosphate | 1980 |
Altered sensitivity to 1-beta-D-arabinofuranosylcytosine 5'-triphosphate of DNA polymerase alpha from leukemic blasts of acute lymphoblastic leukemia.
Topics: Arabinofuranosylcytosine Triphosphate; Arabinonucleotides; DNA Polymerase I; DNA Polymerase II; DNA Polymerase III; Drug Resistance; Humans; Kinetics; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Leukocytes; Nucleic Acid Synthesis Inhibitors | 1982 |
Formation of cytosine arabinoside-5'-triphosphate in different cultured lymphoblastic leukaemic cells with reference to their drug sensitivity.
Topics: Arabinofuranosylcytosine Triphosphate; Child; Cytarabine; Dose-Response Relationship, Drug; Humans; Leukemia, Lymphoid; Time Factors; Tumor Cells, Cultured | 1995 |
Cellular pharmacology of 1-beta-D-arabinofuranosylcytosine in human myeloid, B-lymphoid and T-lymphoid leukemic cells.
Topics: Arabinofuranosylcytosine Triphosphate; Cell Line; Cells, Cultured; Chromatography, High Pressure Liquid; Cytarabine; Deoxycytidine Kinase; DNA, Neoplasm; Humans; Leukemia, B-Cell; Leukemia, Lymphoid; Leukemia, Myeloid; Leukemia, T-Cell; Phosphorylation | 1990 |
Mechanism for ara-CTP catabolism in human leukemic cells and effect of deaminase inhibitors on this process.
Topics: 5'-Nucleotidase; Arabinofuranosylcytosine Triphosphate; Arabinonucleotides; B-Lymphocytes; Cell Line; Cytidine Deaminase; Deoxycytidine Kinase; Humans; Leukemia, Lymphoid; Nucleoside Deaminases; Nucleotidases; T-Lymphocytes; Tetrahydrouridine | 1987 |
Degradation of 1-beta-D-arabinofuranosylcytosine 5'-triphosphate in human leukemic myeloblasts and lymphoblasts.
Topics: Arabinofuranosylcytosine Triphosphate; Arabinonucleotides; Cytarabine; DCMP Deaminase; Guanosine; Half-Life; Humans; Kinetics; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Lymphocytes; Phosphorylation; Thioinosine; Thionucleosides | 1987 |
Biochemical pharmacology of high dose 1-beta-D-arabinofuranosylcytosine in childhood acute leukemia.
Topics: Arabinofuranosylcytosine Triphosphate; Child; Cytarabine; Half-Life; Humans; Leukemia; Leukemia, Lymphoid; Neutropenia | 1987 |
Cytosine arabinoside in the treatment of T-cell acute lymphoblastic leukemia.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Arabinofuranosylcytosine Triphosphate; Combined Modality Therapy; Cytarabine; Female; Humans; Leukemia, Lymphoid; Male; Nucleosides; T-Lymphocytes | 1987 |
Pharmacokinetics and cellular determinants of response to 1-beta-arabinofuranosylcytosine (ara-C).
Topics: Animals; Arabinofuranosylcytosine Triphosphate; Bone Marrow; Cytarabine; Dose-Response Relationship, Drug; Drug Resistance; Humans; Leukemia; Leukemia L1210; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Mice; Mice, Inbred DBA | 1985 |
Evolution of clinical studies with high-dose cytosine arabinoside at the M.D. Anderson Hospital.
Topics: Arabinofuranosylcytosine Triphosphate; Chromosome Aberrations; Cytarabine; Drug Evaluation; Drug Resistance; Half-Life; Humans; Leukemia; Leukemia, Lymphoid; Leukemia, Myeloid; Leukemia, Myeloid, Acute; Prognosis; Time Factors | 1985 |
Cytosine arabinoside transport and metabolism in acute leukemias and T cell lymphoblastic lymphoma.
Topics: Adolescent; Adult; Aged; Arabinofuranosylcytosine Triphosphate; Biological Transport, Active; Biotransformation; Child; Child, Preschool; Cytarabine; Humans; In Vitro Techniques; Leukemia; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Lymphoma, Non-Hodgkin; Middle Aged; T-Lymphocytes | 1985 |